I need to go on vacation. It was just to cheap.
The press and the boards are comparing Belviq to Qsymia and that the slow sales of Qsymia spell disaster for Belviq. But I look at it differently, it means all those people waiting for a new fat pill are not willing to take the risks so they are waiting for Belviq.
Luke - I have to commend you for your conviction, and patience. You are a rock and a rock-star, in my book. Waiting for sub-8 and then acting assetively was a great call.
I had been watching the shares available to short - and it was zero all morning today. "Spiked" to 40k, but this bear-raid was all about the very last chance for shorts to get margin calls on tiny retails. They have no shares left, and when DEA comes along, it is going to be very ugly.
We just need to move the needle up above 8.10 and their "plan" to squeeze out margin players (magic number = $8.00).
Looks like we are getting some support in that effort.
Shorts are working emotions very hard today.
"The press" you refer to is not the trusted names like the NY Times and Washington Post, but basher sites who are paid to slant the news for the likes of mutual funds and big investors who now want to accumulate. The comparison to Qysmia can be done more accurately via Medscape, or WebMD, but most investors are too lazy to actually DD. They would rather prefer to run with the sheep herd over a cliff. Too Bad.
Sentiment: Strong Buy
You are right I should have clarified the shrill press, but I don't know if I would classify the NY Times and a unbiased news source either. Look at the hit piece they did not the Tesla Model S, turned out the report lied and falsified the data and got caught red handed.